These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1378883)

  • 41. Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication.
    Balzarini J; Pelemans H; Aquaro S; Perno CF; Witvrouw M; Schols D; De Clercq E; Karlsson A
    Mol Pharmacol; 1996 Aug; 50(2):394-401. PubMed ID: 8700148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.
    Auwerx J; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2004 Jan; 65(1):244-51. PubMed ID: 14722257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.
    Starnes MC; Cheng YC
    Virus Genes; 1989 May; 2(3):241-51. PubMed ID: 2474897
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
    Margalith M; Falk H; Panet A
    Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 46. [Inhibition of human immunodeficiency virus replication by azidothymidine (Azitidín Lachema) in cultured cells].
    Schmidtmayerová H; Mayer V
    Bratisl Lek Listy; 1993 Feb; 94(2):76-80. PubMed ID: 7689030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.
    Romero DL; Busso M; Tan CK; Reusser F; Palmer JR; Poppe SM; Aristoff PA; Downey KM; So AG; Resnick L
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8806-10. PubMed ID: 1717988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initiation of reverse transcription during cell-to-cell transmission of human immunodeficiency virus infection uses pre-existing reverse transcriptase.
    Li P; Stephenson AJ; Brennan PA; Karageorgos L; Kok T; Kuiper LJ; Swift J; Burrell CJ
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1917-26. PubMed ID: 7519248
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antiviral properties of sterol phosphonoformates.
    Bailey JM; Lightfoote M; Lillehoj E; Nelson K
    Biochem Soc Trans; 1994 Aug; 22(3):353S. PubMed ID: 7529728
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
    Montefiori DC; Robinson WE; Mitchell WM
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
    Rice WG; Schaeffer CA; Graham L; Bu M; McDougal JS; Orloff SL; Villinger F; Young M; Oroszlan S; Fesen MR
    Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9721-4. PubMed ID: 7692451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus.
    Schinazi RF; Chu CK; Babu JR; Oswald BJ; Saalmann V; Cannon DL; Eriksson BF; Nasr M
    Antiviral Res; 1990 May; 13(5):265-72. PubMed ID: 1697740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
    Smith MS; Brian EL; Pagano JS
    J Virol; 1987 Dec; 61(12):3769-73. PubMed ID: 2446006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contribution of multiple rounds of viral entry and reverse transcription to expression of human immunodeficiency virus type 1. A quantitative kinetic study.
    Pellegrino MG; Li G; Potash MJ; Volsky DJ
    J Biol Chem; 1991 Jan; 266(3):1783-8. PubMed ID: 1703155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiviral phospholipids. Anti-HIV drugs conjugated to the glycerobackbone of phospholipids.
    Pidgeon C; Markovich RJ; Liu MD; Holzer TJ; Novak RM; Keyer KA
    J Biol Chem; 1993 Apr; 268(11):7773-8. PubMed ID: 7681828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function.
    Nokta M; Albrecht T; Pollard R
    Immunopharmacology; 1993; 26(2):181-5. PubMed ID: 7506701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
    Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
    AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
    Tyms AS; Davis JM; Clarke JR; Jeffries DJ
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1563-73. PubMed ID: 3035060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-to-cell transmission of human immunodeficiency virus infection induces two distinct phases of viral RNA expression under separate regulatory control.
    Kok T; Li P; Burrell C
    J Gen Virol; 1993 Jan; 74 ( Pt 1)():33-8. PubMed ID: 8423449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of human immunodeficiency virus (HIV-1) replication in vitro by noncytotoxic doses of camptothecin, a topoisomerase I inhibitor.
    Priel E; Showalter SD; Blair DG
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):65-72. PubMed ID: 1707642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.